APA (7th ed.) Citation

A, F., M, S., E, O., M, P., M, B., LR, V., . . . MP, M. (2024). N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma. Cancer medicine, 13(19), e70279. https://doi.org/10.1002/cam4.70279

Chicago Style (17th ed.) Citation

A, Formato, et al. "N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma." Cancer Medicine 13, no. 19 (2024): e70279. https://doi.org/10.1002/cam4.70279.

MLA (9th ed.) Citation

A, Formato, et al. "N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma." Cancer Medicine, vol. 13, no. 19, 2024, p. e70279, https://doi.org/10.1002/cam4.70279.